Humphrey Polanen - Deep Medicine CEO Chairman
| DMAQDelisted Stock | USD 11.59 0.12 1.02% |
Insider
Humphrey Polanen is CEO Chairman of Deep Medicine Acquisition
| Age | 74 |
| Phone | 917 289 2776 |
Deep Medicine Management Efficiency
The company has return on total asset (ROA) of (0.0176) % which means that it has lost $0.0176 on every $100 spent on assets. This is way below average. Deep Medicine's management efficiency ratios could be used to measure how well Deep Medicine manages its routine affairs as well as how well it operates its assets and liabilities.Deep Medicine Acquisition currently holds 1.86 M in liabilities. Deep Medicine Acquisition has a current ratio of 224.96, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Deep Medicine's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Abhishek Bawa | ClimateRock Class A | 41 | |
| David Chu | Alpha One | N/A | |
| Shahal Khan | BurTech Acquisition Corp | 51 | |
| Ajay Chowdhery | Portage Fintech Acquisition | 40 | |
| Adam Felesky | Portage Fintech Acquisition | 48 | |
| Per Regnarsson | ClimateRock Class A | 58 | |
| Thomas Lu | Alpha One | N/A | |
| Yuneng Ho | Alpha One | 48 | |
| HsiuPin CPA | Alpha One | N/A | |
| Payel Farasat | BurTech Acquisition Corp | 45 | |
| Jeffrey CPA | Insight Acquisition Corp | 61 | |
| Christopher Schroeder | BurTech Acquisition Corp | 55 | |
| ChuanChen Hu | Alpha One | 65 | |
| Roman Livson | BurTech Acquisition Corp | 54 | |
| Haining Zhang | Alpha One | N/A | |
| FuShan Shen | Alpha One | 65 | |
| Joseph Chuang | Alpha One | N/A | |
| Yuying Jen | Alpha One | 52 | |
| TsengChien Huang | Alpha One | N/A | |
Management Performance
| Return On Asset | -0.0176 |
Deep Medicine Acquisition Leadership Team
Elected by the shareholders, the Deep Medicine's board of directors comprises two types of representatives: Deep Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Deep. The board's role is to monitor Deep Medicine's management team and ensure that shareholders' interests are well served. Deep Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Deep Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Humphrey Polanen, CEO Chairman | ||
| MS CPA, Chief Officer |
Deep Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Deep Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0176 | |||
| Current Valuation | 15.74 M | |||
| Shares Outstanding | 4.36 M | |||
| Shares Owned By Insiders | 74.08 % | |||
| Shares Owned By Institutions | 28.73 % | |||
| Number Of Shares Shorted | 10.3 K | |||
| Price To Book | 22.01 X | |||
| EBITDA | (3.99 M) | |||
| Net Income | (400.23 K) | |||
| Cash And Equivalents | 707.98 K |
Pair Trading with Deep Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deep Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deep Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Deep Stock
| 0.85 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.84 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.82 | BKRKY | Bank Rakyat | PairCorr |
| 0.82 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Deep Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deep Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deep Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deep Medicine Acquisition to buy it.
The correlation of Deep Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deep Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deep Medicine Acquisition moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deep Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Deep Stock
If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |